Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,700
-130 (-1.01%)
At close: Jul 25, 2025, 3:30 PM KST
-1.01%
Market Cap674.33B
Revenue (ttm)222.50B
Net Income (ttm)-13.49B
Shares Out51.26M
EPS (ttm)-263.13
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume80,085
Average Volume399,049
Open12,830
Previous Close12,830
Day's Range12,520 - 12,890
52-Week Range6,400 - 20,500
Beta2.20
RSI43.42
Earnings DateAug 14, 2025

About KRX:019170

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; woun... [Read more]

Sector Healthcare
Founded 1962
Employees 819
Stock Exchange Korea Stock Exchange
Ticker Symbol 019170
Full Company Profile

Financial Performance

In 2024, KRX:019170's revenue was 221.09 billion, an increase of 10.42% compared to the previous year's 200.23 billion. Losses were -14.82 billion, -74.15% less than in 2023.

Financial Statements

News

There is no news available yet.